Why the study?
Does drug treatment with beta-blockers and diuretics reduce cardiovascular morbidity and mortality in hypertensive patients aged 70 and above?
Does drug treatment with beta-blockers and diuretics reduce cardiovascular morbidity and mortality in hypertensive patients aged 70 and above?
Antihypertensive therapy with beta-blockers and diuretics in patients aged 70 and older is well-tolerated, cost-effective, and significantly reduces cardiovascular morbidity and mortality, particularly stroke.
Supports beta-blocker/diuretic therapy in elderly hypertensives; leaves open need for contemporary RCTs.
Drug treatment with beta-blockers and diuretics in hypertensive men and women aged 70 and above confers highly significant and clinically relevant reductions in cardiovascular (especially stroke) morbidity and mortality. This satisfactory effect is not impaired by a low tolerability of the drugs used. Furthermore, treatment of elderly hypertensives with beta-receptor blockers and/or diuretics is cost-effective. In STOP-Hypertension the cost-effectiveness ratios were low and of the same magnitude for both men and women. The clinical implication of this is that blood pressure lowering therapy should be considered in elderly hypertensives, at least up until they are 80 years old. It should also be remembered that elderly patients often have other diseases than hypertension and that the drug treatment should be adjusted accordingly, e.g. by using a calcium antagonist or an ACE inhibitor, when indicated.
No takes yet. Share an insight, caveat, or question.
Lars Lindholm (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: